Melanopsin mediates light-dependent relaxation in blood vessels

Gautam Sikka, G. Patrick Hussmann, Deepesh Pandey, Suyi Cao, Daijiro Hori, Jong Taek Park, Jochen Steppan, Jae Hyung Kim, Viachaslau Barodka, Allen C. Myers, Lakshmi Santhanam, Daniel Nyhan, Marc K Halushka, Raymond C Koehler, Solomon H Snyder, Larissa Shimoda, Dan E Berkowitz

Research output: Contribution to journalArticle

Abstract

Melanopsin (opsin4; Opn4), a non-image-forming opsin, has been linked to a number of behavioral responses to light, including circadian photo-entrainment, light suppression of activity in nocturnal animals, and alertness in diurnal animals. We report a physiological role for Opn4 in regulating blood vessel function, particularly in the context of photorelaxation. Using PCR, we demonstrate that Opn4 (a classic G protein-coupled receptor) is expressed in blood vessels. Force-tension myography demonstrates that vessels from Opn4-/- mice fail to display photorelaxation, which is also inhibited by an Opn4-specific small-molecule inhibitor. The vasorelaxation is wavelength-specific, with a maximal response at ∼430-460 nm. Photorelaxation does not involve endothelial-, nitric oxide-, carbon monoxide-, or cytochrome p450-derived vasoactive prostanoid signaling but is associatedwith vascular hyperpolarization, as shown by intracellular membrane potential measurements. Signaling is both soluble guanylyl cyclase- and phosphodiesterase 6-dependent but protein kinase G-independent. β-Adrenergic receptor kinase 1 (βARK 1 or GRK2) mediates desensitization of photorelaxation, which is greatly reduced by GRK2 inhibitors. Blue light (455 nM) regulates tail artery vasoreactivity ex vivo and tail blood blood flow in vivo, supporting a potential physiological role for this signaling system. This endogenous opsin-mediated, lightactivated molecular switch for vasorelaxation might be harnessed for therapy in diseases in which altered vasoreactivity is a significant pathophysiologic contributor.

Original languageEnglish (US)
Pages (from-to)17977-17982
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number50
DOIs
StatePublished - Dec 16 2014

Fingerprint

Opsins
Blood Vessels
Light
Vasodilation
Tail
Type 6 Cyclic Nucleotide Phosphodiesterases
Myography
Cyclic GMP-Dependent Protein Kinases
Intracellular Membranes
Carbon Monoxide
G-Protein-Coupled Receptors
Membrane Potentials
Cytochrome P-450 Enzyme System
Adrenergic Receptors
Prostaglandins
Nitric Oxide
Phosphotransferases
Arteries
Polymerase Chain Reaction
melanopsin

Keywords

  • GRK2
  • Melanopsin
  • Opsin
  • Photorelaxation
  • Signal transduction

ASJC Scopus subject areas

  • General

Cite this

Melanopsin mediates light-dependent relaxation in blood vessels. / Sikka, Gautam; Hussmann, G. Patrick; Pandey, Deepesh; Cao, Suyi; Hori, Daijiro; Park, Jong Taek; Steppan, Jochen; Kim, Jae Hyung; Barodka, Viachaslau; Myers, Allen C.; Santhanam, Lakshmi; Nyhan, Daniel; Halushka, Marc K; Koehler, Raymond C; Snyder, Solomon H; Shimoda, Larissa; Berkowitz, Dan E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 50, 16.12.2014, p. 17977-17982.

Research output: Contribution to journalArticle

@article{86e9385ae8a940e4a89301d67a5f0170,
title = "Melanopsin mediates light-dependent relaxation in blood vessels",
abstract = "Melanopsin (opsin4; Opn4), a non-image-forming opsin, has been linked to a number of behavioral responses to light, including circadian photo-entrainment, light suppression of activity in nocturnal animals, and alertness in diurnal animals. We report a physiological role for Opn4 in regulating blood vessel function, particularly in the context of photorelaxation. Using PCR, we demonstrate that Opn4 (a classic G protein-coupled receptor) is expressed in blood vessels. Force-tension myography demonstrates that vessels from Opn4-/- mice fail to display photorelaxation, which is also inhibited by an Opn4-specific small-molecule inhibitor. The vasorelaxation is wavelength-specific, with a maximal response at ∼430-460 nm. Photorelaxation does not involve endothelial-, nitric oxide-, carbon monoxide-, or cytochrome p450-derived vasoactive prostanoid signaling but is associatedwith vascular hyperpolarization, as shown by intracellular membrane potential measurements. Signaling is both soluble guanylyl cyclase- and phosphodiesterase 6-dependent but protein kinase G-independent. β-Adrenergic receptor kinase 1 (βARK 1 or GRK2) mediates desensitization of photorelaxation, which is greatly reduced by GRK2 inhibitors. Blue light (455 nM) regulates tail artery vasoreactivity ex vivo and tail blood blood flow in vivo, supporting a potential physiological role for this signaling system. This endogenous opsin-mediated, lightactivated molecular switch for vasorelaxation might be harnessed for therapy in diseases in which altered vasoreactivity is a significant pathophysiologic contributor.",
keywords = "GRK2, Melanopsin, Opsin, Photorelaxation, Signal transduction",
author = "Gautam Sikka and Hussmann, {G. Patrick} and Deepesh Pandey and Suyi Cao and Daijiro Hori and Park, {Jong Taek} and Jochen Steppan and Kim, {Jae Hyung} and Viachaslau Barodka and Myers, {Allen C.} and Lakshmi Santhanam and Daniel Nyhan and Halushka, {Marc K} and Koehler, {Raymond C} and Snyder, {Solomon H} and Larissa Shimoda and Berkowitz, {Dan E}",
year = "2014",
month = "12",
day = "16",
doi = "10.1073/pnas.1420258111",
language = "English (US)",
volume = "111",
pages = "17977--17982",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "50",

}

TY - JOUR

T1 - Melanopsin mediates light-dependent relaxation in blood vessels

AU - Sikka, Gautam

AU - Hussmann, G. Patrick

AU - Pandey, Deepesh

AU - Cao, Suyi

AU - Hori, Daijiro

AU - Park, Jong Taek

AU - Steppan, Jochen

AU - Kim, Jae Hyung

AU - Barodka, Viachaslau

AU - Myers, Allen C.

AU - Santhanam, Lakshmi

AU - Nyhan, Daniel

AU - Halushka, Marc K

AU - Koehler, Raymond C

AU - Snyder, Solomon H

AU - Shimoda, Larissa

AU - Berkowitz, Dan E

PY - 2014/12/16

Y1 - 2014/12/16

N2 - Melanopsin (opsin4; Opn4), a non-image-forming opsin, has been linked to a number of behavioral responses to light, including circadian photo-entrainment, light suppression of activity in nocturnal animals, and alertness in diurnal animals. We report a physiological role for Opn4 in regulating blood vessel function, particularly in the context of photorelaxation. Using PCR, we demonstrate that Opn4 (a classic G protein-coupled receptor) is expressed in blood vessels. Force-tension myography demonstrates that vessels from Opn4-/- mice fail to display photorelaxation, which is also inhibited by an Opn4-specific small-molecule inhibitor. The vasorelaxation is wavelength-specific, with a maximal response at ∼430-460 nm. Photorelaxation does not involve endothelial-, nitric oxide-, carbon monoxide-, or cytochrome p450-derived vasoactive prostanoid signaling but is associatedwith vascular hyperpolarization, as shown by intracellular membrane potential measurements. Signaling is both soluble guanylyl cyclase- and phosphodiesterase 6-dependent but protein kinase G-independent. β-Adrenergic receptor kinase 1 (βARK 1 or GRK2) mediates desensitization of photorelaxation, which is greatly reduced by GRK2 inhibitors. Blue light (455 nM) regulates tail artery vasoreactivity ex vivo and tail blood blood flow in vivo, supporting a potential physiological role for this signaling system. This endogenous opsin-mediated, lightactivated molecular switch for vasorelaxation might be harnessed for therapy in diseases in which altered vasoreactivity is a significant pathophysiologic contributor.

AB - Melanopsin (opsin4; Opn4), a non-image-forming opsin, has been linked to a number of behavioral responses to light, including circadian photo-entrainment, light suppression of activity in nocturnal animals, and alertness in diurnal animals. We report a physiological role for Opn4 in regulating blood vessel function, particularly in the context of photorelaxation. Using PCR, we demonstrate that Opn4 (a classic G protein-coupled receptor) is expressed in blood vessels. Force-tension myography demonstrates that vessels from Opn4-/- mice fail to display photorelaxation, which is also inhibited by an Opn4-specific small-molecule inhibitor. The vasorelaxation is wavelength-specific, with a maximal response at ∼430-460 nm. Photorelaxation does not involve endothelial-, nitric oxide-, carbon monoxide-, or cytochrome p450-derived vasoactive prostanoid signaling but is associatedwith vascular hyperpolarization, as shown by intracellular membrane potential measurements. Signaling is both soluble guanylyl cyclase- and phosphodiesterase 6-dependent but protein kinase G-independent. β-Adrenergic receptor kinase 1 (βARK 1 or GRK2) mediates desensitization of photorelaxation, which is greatly reduced by GRK2 inhibitors. Blue light (455 nM) regulates tail artery vasoreactivity ex vivo and tail blood blood flow in vivo, supporting a potential physiological role for this signaling system. This endogenous opsin-mediated, lightactivated molecular switch for vasorelaxation might be harnessed for therapy in diseases in which altered vasoreactivity is a significant pathophysiologic contributor.

KW - GRK2

KW - Melanopsin

KW - Opsin

KW - Photorelaxation

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84918499526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918499526&partnerID=8YFLogxK

U2 - 10.1073/pnas.1420258111

DO - 10.1073/pnas.1420258111

M3 - Article

C2 - 25404319

AN - SCOPUS:84918499526

VL - 111

SP - 17977

EP - 17982

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 50

ER -